ArticleCost effectiveness and resource allocation : C/E2019

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients.

Yogesh Suresh Punekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.